6505--Imatinib Tablets

The Department of Veterans Affairs National Acquisition Center seeks offers for Imatinib Mesylate tablets in two strengths through the VA and DoD Pharmaceutical Prime Vendor Programs, with proposals due October 30, 2026, at 2:30 PM local time. No set-aside applies.

Line Item 1 is 100MG, 90 tablets per bottle, with estimated annual usage of 6,397 bottles. Line Item 2 is 400MG, 30 tablets per bottle, with estimated annual usage of 19,504 bottles. One award will be made in the aggregate for both line items. The contract includes a base year and four one-year option periods; pricing must be submitted for all periods and include a mandatory 0.5% Cost Recovery Fee. The 60-day maximum Implementation Period begins upon award, or extends to February 26, 2027, if award occurs before December 28, 2026.

Products must be supplied in unit-of-use packaging with 120cc minimum bottle volume, 5.75" circumference, and safety caps. All offerings require a unique 11-digit NDC number and GS1-128 or HIBC bar code labeling at the unit-of-use level. Manufacturing facilities must hold FDA-compliant current Good Manufacturing Practices certification. Contractors must comply with Drug Supply Chain Security Act requirements, including EPCIS transaction files and NABP Trading Partner Directory registration, and register products with FDA, First Databank, Oracle Cerner/Multum, and Medispan within five days of award. Non-manufacturer offerors must provide a Letter of Commitment from the manufacturer. The contractor must establish and maintain business-to-business agreements with PPV contractors, submit quarterly sales reports, and remit Cost Recovery Fees. Covered drug prices must not exceed the Federal Ceiling Price plus the 0.5% Cost Recovery Fee under 38 U.S.C. 8126.

Government participants include VA facilities, DoD Ordering Activities, IHS facilities, BOP facilities, Captain James A. Lovell FHCC, and State Veteran Homes under Option 2. Proposals must be submitted via email in Microsoft Word or PDF format with a scanned signed SF-1449; faxed submissions will be rejected. NAICS code is 325412, Pharmaceutical Preparation Manufacturing; PSC is 6505, Drugs and Biologicals.